Clinical Trial Update: A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan

View source ↗

Summary

A completed clinical trial evaluating label compliance for ADHD medications in Japan. The study was sponsored by Janssen Research & Development, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Attention Deficit Disorder With Hyperactivity | Status: COMPLETED